HCW Biologics (HCWB) Interest & Investment Income (2020 - 2021)
HCW Biologics' (HCWB) quarterly Interest & Investment Income came in at $631.0 in Q2 2021, down 58.54% on a YoY basis from $1522.0 in Q2 2020, and down 58.54% quarter-over-quarter from $1522.0 in Q2 2020.
Powered by 
Analysis
HCW Biologics (HCWB) Interest & Investment Income (2020 - 2021) Analysis & Trends
HCW Biologics (HCWB) has reported Interest & Investment Income for 2 consecutive years, with $631.0 the latest figure, recorded in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 120.60 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | -48.00 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 48.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 67.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 10.98 Mn |
| 10 | HCW Biologics | 3.90 Mn | 3.16 Mn | -93,887.00 | - |